Lallemand Health Solutions

Activities: Ingredients Digestion

With 90 years of know-how, Lallemand Health Solutions, a global leader in the probiotic industry, specializes in the development, production, and marketing of bacteria and yeast-based probiotic supplements for human health, food applications, nutricosmetics, and contract development and manufacturing (CDMO). Our manufacturing facilities adhere to the highest quality standards, including Good Manufacturing Practices. Our ambitious research program with the Rosell Institute for Microbiome and Probiotics enables us to provide partners with probiotic strains that are documented for various health applications, including gut health, natural defenses, mental health, women’s health, skin health, oral health, metabolic health, and sport and babies applications. Currently, we market more than 600 probiotic formulas in over 60 countries across five continents.

Visit website

Profile

About research and development at Lallemand Health Solutions

The major R&D challenges focus on the development and characterization of the effects of first and new generation probiotics on human health. Lallemand Health Solutions has integrated platforms for preclinical, clinical, galenic and bioprocess development, and a dedicated R&D team of 40 people, notably managing some twenty clinical trials on five continents. The division’s production plants operate according to Good Manufacturing Practices (GMP), including one site holding a manufacturing authorization according to GMP for medicinal products for human use (Saint-Simon, France).

HEADLINES 2024

Lallemand Health Solutions

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through contract development and manufacturing operations, with the launch of Expert’Biome™ CDMO by Lallemand. With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and other production steps. Contact her for your projects: expertbiome@lallemand.com.

Lallemand Health Solutions

Don’t forget to follow us on LinkedIn to know when new blog articles are posted, to get news and trends about probiotics and their health applications and much more!

Contact us for more details healthsolutions@lallemand.com

Social media

 

Lallemand Health Solutions

 

Trending Articles

  1. Kerry debuts 2025 health and nutrition report in collaboration with over 100 industry experts The company forecasts the trends that the nutraceutical, functional food and supplement industries may see in the upcoming year
  2. Brevel completes construction of industrial-scale microalgae fermentation plant The fermentation plant will be able to produce microalgae-derived proteins for the functional food and nutrition markets at an industrial scale
  3. HTBA showcases the power of flavonoids at Fi Europe The nutraceutical and functional beverage provider will display its range of products for active nutrition and cognitive health, while also showcasing its flavour modulation...
  4. Astaxanthin gives athletes the edge Natural astaxanthin is an excellent nutrient for athletes and active people; it can help them in several important ways
  5. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight

Upcoming event

Fi Europe 2024

19-21 November 2024 | Exhibition | Frankfurt, Germany See all

Related Content

Ingredients

Lallemand inaugurates new research and development laboratories

New R&D facilities in France to enhance innovation in microbial solutions across multiple sectors
Ingredients

Prenatis Nurturing Life, From Mom to Baby

Prenatis is Lallemand Health Solutions’ newest probiotic formulation. It combines two proprietary strains known for their safety and efficacy: L. rhamnosus Rosell-11 and B. bifidum HA-132
Ingredients

Lallemand Health Solutions presents innovation range at Vitafoods Europe

The company will showcase its solutions to support the infant microbiome pre and postnatally, as well as its advancements in the nutricosmetic space
Ingredients

Discover Prenatis: Nurturing life, from mom to baby

Meet Lallemand Health Solutions’ team at Vitafoods Europe to discover an exciting newprobiotic formula: Prenatis
Ingredients

dsm-firmenich and Lallemand partner to launch early life synbiotic solutions

The solution will contain a combination of human milk oligosaccharides (HMOs) that will mimic breast milk, boosting the infant immune system and gut microbiome
Ingredients

Health Canada confirms L. plantarum Rosella can support vaginal health

The probiotic strain has been recognised to support a healthy vaginal microflora and assist in reducing the recurrence of vulvovaginal candidiasis
Finance

Lallemand completes acquisition of Evolva

Lallemand, a global leader in industrial biotechnology, has confirmed the closing in December 2023 of the acquisition by its subsidiary Danstar Ferment AG of Swiss biotechnology business Evolva AG from Evolva Holding AG
Subscribe now